Descrição

With the advancements in the healthcare industry, plastic has proved to be one of the few versatile materials that has been used widely to create medical tools and devices like surgical gloves, syringes, insulin pens, IV tubes, catheters, etc.. The global medical plastics market in terms of revenue is set to grow by US$ 8 bilhão durante 2021-2027, crescendo a uma taxa composta de crescimento anual (CAGR) de 5.6% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix. Rising disposable income, mudando estilos de vida, growing demand for better healthcare facilities coupled with rise in health concerns among consumers are the key factors driving market growth.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2017-2020 e previsão para 2027 covering key market aspects like sales value and volume for medical plastics. The global medical plastics market is segmented on the basis of product, aplicativo, region. Por produto, it is categorized into commodity thermoplastics, engineering thermoplastics, TPEs, thermosets, high performance plastic (HPP), and miscellaneous. The commodity thermoplastics segment held the largest market share in 2020. By application, the medical plastics market is divided into medical disposables, surgical instruments, diagnostic equipment, prostheses/implants, embalagem, e outros. The medical disposables segment accounted for the largest market share in 2020. Based on region, the medical plastics market is divided into North America, Ásia-Pacífico, Europa, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as Borealis AG, Chi Mei Corporation, Covestro AG, Dow Silicones Corporation, DuPont de Nemours Inc., Formosa Plastics Corporation, Kraton Corporation, LCY Chemical Corporation, LG Chem Ltd., LyondellBasell Industries N.V., Mitsubishi Engineering-Plastics Corporation, Momentive Performance Materials Inc., Saudi Basic Industries Corporation (SABIC), Shin-Etsu Chemical Co. Ltda..

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the medical plastics market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

produtos: commodity thermoplastics, engineering thermoplastics, TPEs, thermosets, high performance plastic (HPP), and miscellaneous
Aplicativo: medical disposables, surgical instruments, diagnostic equipment, prostheses/implants, embalagem, e outros
Região: América do Norte, Ásia-Pacífico, Europa, and Rest of the World (ROW)
Anos considerados: este relatório cobre o período 2017 para 2027

Principais benefícios para as partes interessadas

Get a comprehensive picture of the global medical plastics market
Identifique setores de crescimento e tendências para investimento
Understand what the future of the global medical plastics market looks like
Identifique o cenário competitivo e a janela de oportunidade

Índice

1. Definição de mercado
2. Metodologia de Pesquisa
3. Dados de mercado & Panorama
3.1 Valor de mercado
3.2 Previsão de valor de mercado
4. Medical Plastics Market by Product
4.1 Commodity Thermoplastics
4.2 Engineering Thermoplastics
4.3 Tpes
4.4 Thermosets
4.5 High Performance Plastic (Hpp)
4.6 Miscellaneous
5. Medical Plastics Market by Application
5.1 Medical Disposables
5.2 Surgical Instruments
5.3 Diagnostic Equipment
5.4 Prostheses/Implants
5.5 Embalagem
5.6 Outros
6. Medical Plastics Market by Region
6.1 América do Norte
6.2 Ásia-Pacífico
6.3 Europa
6.4 Rest Of The World (Row)
7. Perfis de empresa
7.1 Borealis AG
7.2 Chi Mei Corporation
7.3 Covestro AG
7.4 Dow Silicones Corporation
7.5 DuPont de Nemours, Inc..
7.6 Formosa Plastics Corporation
7.7 Kraton Corporation
7.8 LCY Chemical Corporation
7.9 LG Chem Ltd.
7.10 LyondellBasell Industries N.V.
7.11 Mitsubishi Engineering-Plastics Corporation
7.12 Momentive Performance Materials Inc.
7.13 Saudi Basic Industries Corporation (SABIC)
7.14 Shin-Etsu Chemical Co., Ltda.
8. Apêndice
8.1 Sobre StrategyHelix
8.2 Isenção de responsabilidade